Category Archives: Vioxx

Featured Stories

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Vioxx Off-Label Marketing To Cost Merck $321 Million

Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx | Tagged |

Merck Agrees to Pay $950 Million to Settle Vioxx Marketing Charges

Merck has agreed to pay $950 million to settle Vioxx marketing charges. Pleading guilty to illegally advertising now-banned painkiller Vioxx (rofecoxib), Merck Sharp & Dohme will be paying millions in fines and penalties to the United States government as well … Continue reading

Posted in Pharmaceuticals, Vioxx |

Supreme Court Gives Go Ahead to Vioxx Investor Lawsuit

Yesterday, the U.S. Supreme Court gave the go-ahead for a securities fraud lawsuit against pharmaceutical giant, Merck & Co Inc., over its disclosures to investors about < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a … Continue reading

Posted in Class Action Lawsuits, Health Concerns, Pharmaceuticals, Vioxx, Vioxx |

Merck Loses Australian Vioxx Lawsuit

We just wrote that Merck & Co. made a final $4.1 billion payment to its < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx settlement fund. According to a recent Associated Press (AP) report, final payouts to former Vioxx users or their survivors should be made by … Continue reading

Posted in Class Action Lawsuits, Vioxx |

Vioxx Shareholder Lawsuit Before US Supreme Court

Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx |

Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs

Medical journals have been asked to retract 21 studies that touted the benefits of < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx, < "http://www.yourlawyer.com/topics/overview/stevens_johnson_syndrome">Celebrex and other drugs. According to The Wall Street Journal, Baystate Medical Center, Springfield, Mass. is asking the journals to make the retractions … Continue reading

Posted in Class Action Lawsuits, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Grand Jury Probe Latest Headache for Merck

Just as < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx maker Merck gets closer to settling thousands of lawsuits against the defective pain reliever, reports have surfaced that a grand jury is investigating the company over the way it marketed Vioxx. According to the Wall Street … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Vioxx, Vioxx |

Florida Vioxx Plaintiffs Look to Expand Settlement

< "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx plaintiffs in Florida are petitioning a federal court to expand Merck’s proposed $4.85 billion settlement to include those who did not file suit against the company by Nov. 9, 2007.  But many lawyers involved in the Vioxx settlement … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Victims to Share $4.85 Billion under Settlement Agreement with Merck

Vioxx maker Merck will spend $4.85 billion to settle a significant number of lawsuits filed against it for injuries caused by the painkiller. Under the agreement, which was announced late yesterday, Merck will set up two separate settlement funds to … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Product Recalls, Recalled Drugs, Vioxx, Vioxx |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.